CompanyIntelligence | Amgen, Inc.

The Consus Group provides critical intelligence for the
business, investor, and legal communities.

Documents can be downloaded immediately after purchase. Complete your order by clicking the Add-to-Cart button.

$71	Subscribers Preview	2002	Asset Purchase Agreement	Schering Aktiengesellschaft; Immunex Corporation; Amgen	Wyeth; Cravath; Skadden
$94	Subscribers Preview	2002	Asset Purchase Agreement	Abbott Labs; Amgen; Wyeth	Cravath; Skadden
$59	Subscribers Preview	2000	Preferred and Common Stock Purchase Agreement	Amgen; Array BioPharma	Holme Roberts
$39	Subscribers Preview	2001	Purchase Agreement	Amgen; Regeneron Pharma; J.P. Morgan	Merrill Lynch 2 3
$60	Subscribers Preview	2001	Purchase Agreement	Amgen; Regeneron Pharma; J.P. Morgan	Merrill Lynch 2 3
$49	Subscribers Preview	2001	Purchase Agreement	Amgen; Regeneron Pharma; J.P. Morgan	Merrill Lynch 2
$49	Subscribers Preview	2004	Purchase Agreement	Amgen; Barclays Capital; Bear, Stearns	Cede 2 3 4 2
$63	Subscribers Preview	2001	Purchase Agreement	Amgen; Regeneron Pharma; J.P. Morgan	Merrill Lynch 2 3
$37	Subscribers Preview	2003	Restricted Stock Purchase Agreement	Amgen, Inc.
$35	Subscribers	2003	Restricted Stock Purchase Agreement	Amgen, Inc.
$38	Subscribers	2002	Restricted Stock Purchase Agreement	Amgen, Inc.
$31	Subscribers	2002	Restricted Stock Purchase Agreement	Amgen, Inc.
$40	Subscribers	2001	Restricted Stock Purchase Agreement	Amgen, Inc.
$40	Subscribers	2001	Restricted Stock Purchase Agreement	Amgen, Inc.
$80	Subscribers Preview	2000	Series C Preferred Stock Purchase Agreement	Amgen; Array BioPharma; SVB	Tripos 2
$43	Subscribers Preview	2003	Stock Purchase Agreement	Amgen; Tularik	Wells Fargo Bank; Cooley Godward
$52	Subscribers Preview	2003	Stock Purchase Agreement	Genome Therapeutics Corp; Amgen	Nasdaq Stock Market Inc.
$49	Subscribers Preview	2003	Stock Purchase Agreement	Genome Therapeutics Corp; Amgen	Nasdaq Stock Market Inc.
$62	Subscribers Preview	2003	Stock Purchase Agreement	Amgen; Tularik	Wells Fargo Bank; Cooley Godward
$54	Subscribers Preview	2003	Stock Purchase Agreement	Amgen; Oscient Pharma	Nasdaq Stock Market Inc.